Clinic
Upper Hudson Planned Parenthood INC.
Upper Hudson Planned Parenthood INC. was paid $5.30M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoUPPER HUDSON PLANNED PARENTHOOD INC.
ALBANY, NY 12206
ALBANY, NY 12206
33aNPI1881755601assigned 12/13/2006
33bProvider typeClinic/Center
28Total paid$5.30M
24GClaims119,327
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New York
Rank by total paid#60 of 235
Median peer was paid$630K
This provider vs. median8.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,594 | $733K | |
| 2019 | 17,311 | $804K | |
| 2020 | 21,820 | $902K | |
| 2021 | 20,957 | $782K | |
| 2022 | 18,163 | $760K | |
| 2023 | 17,616 | $755K | |
| 2024incomplete | 12,866 | $562K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 16,723 | 11,077 | $1.88M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 5,544 | 4,705 | $726K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 7.2% | 4,276 | 4,066 | $380K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.0% | 3,400 | 2,183 | $369K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.3% | 1,934 | 1,653 | $282K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.1% | 2,943 | 1,559 | $269K |
| 59840 | 4.5% | 365 | 365 | $237K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.3% | 7,927 | 7,785 | $229K |
| S0190 | Mifepristone, oral, 200 mg | 2.6% | 2,595 | 2,584 | $136K |
| 81025 | 2.5% | 17,137 | 15,575 | $131K | |
| 99201 | 2.0% | 1,264 | 576 | $104K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.8% | 7,916 | 7,794 | $97K |
36 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.8% | 564 | $95K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1.2% | 2,333 | $62K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 4,809 | $56K |
| 96127 | 1.0% | 17,938 | $53K | |
| 86703 | <1% | 2,900 | $52K | |
| 76830 | Ultrasound, transvaginal | <1% | 351 | $28K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 271 | $27K |
| 59841 | <1% | 38 | $24K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,167 | $13K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 2,662 | $6K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 271 | $5K |
| 88141 | <1% | 220 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 179 | $4K |
| 86701 | <1% | 512 | $4K | |
| 99051 | <1% | 388 | $3K | |
| 58300 | <1% | 25 | $3K | |
| 86901 | <1% | 85 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,367 | $2K |
| 88142 | <1% | 85 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 136 | $2K |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | <1% | 80 | $2K |
| 87210 | <1% | 1,356 | $2K | |
| 85018 | <1% | 1,751 | $2K | |
| 86803 | <1% | 996 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $367.39 |
| 90385 | <1% | 25 | $364.52 | |
| 86780 | <1% | 2,197 | $359.85 | |
| 85027 | <1% | 226 | $246.70 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $235.72 |
| 84403 | <1% | 67 | $185.85 | |
| 86592 | <1% | 177 | $41.11 | |
| 81002 | <1% | 52 | $13.90 | |
| S5000 | Prescription drug, generic | <1% | 138 | $7.00 |
| 83986 | <1% | 814 | $6.74 | |
| S5001 | Prescription drug, brand name | <1% | 86 | $1.75 |
| 87340 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEGAN, MICHELLE (PRESIDENT/CEO)